![](https://healthpolicy.usc.edu/wp-content/uploads/2024/07/Estimating-Overpayments-To-MA-650x350.jpg)
Perspective
Featured Topics
Lead story
Other featured articles
-
Access to New Alzheimer’s Treatments Bogged Down by Medicare Policy
There are now two Alzheimer’s treatments with significant clinical benefit. It’s not clear how quickly patients will be able to benefit.
Posted in -
How To Advance The Debate Over QALYs: A Response To Kaplan et al.
Jason Doctor and Darius Lakdawalla respond to a recent Health Affairs Forefront article by Robert Kaplan and colleagues and call for an alternative to QALYs, given issues with the underlying assumptions.
Posted in -
Improving Access to Medigap When Beneficiaries Leave Medicare Advantage
For beneficiaries switching from Medicare Advantage, state regulations generally permit Medigap plans to deny coverage, impose waiting periods, or charge higher premiums.
Posted in -
Let the Market Determine Drug Prices – Not 19th Century Economics
In health care, the term “value” gets lobbed about quite loosely. It is easy to forget that centuries of economic thought have gone into rigorously examining how worth is determined in a marketplace.
Posted in
ADDITIONAL Perspectives
-
In the Wake of the Pandemic: How and Why Housing Plans are Changing in L.A.
Nearly all Angelenos plan to stay put in L.A. Four years ago, they were fleeing in record numbers. What changed in our nation’s most populous county? LABarometer survey data suggest financial constraints kept many low-income residents in place; now, a growing number of these residents appear at risk of displacement.
Categorized in -
Medicare Can Follow Blazed Trails to Revitalize Alzheimer’s Care
If Medicare is allowed to step up to the challenge of Alzheimer’s, patients could receive affordable and good quality care as soon as their disease develops.
Categorized in -
Medicare Coverage of Weight Loss Drugs Could Save the U.S. Billions of Dollars
The new weight loss drugs work, and represent huge value in treating obesity. Even though they are expensive, broader access to them via Medicare would end up saving the U.S. money.
Categorized in -
Buyouts Can Bring Relief From Medical Debt, but They’re Far From a Cure
Local governments are increasingly buying – and forgiving – their residents’ medical debt.
Categorized in -
Medicare’s Mental Health Care Problem
Mental health care providers are subject to unique constraints and incentives, compared to other specialists.
Categorized in -
Knowing Actual Prices Will Help HHS Set the Maximum Fair Price under the Inflation Reduction Act
Requiring data on actual net costs will improve negotiations over the “maximum fair price” for select drugs under Medicare.
Categorized in